Biography
Dr Wynand van de Ven (1950) wrote his thesis "Studies in Health Insurance and Econometrics" at Leiden University. Since 1986 he is professor of Health Insurance at the Erasmus University Rotterdam. His teaching and research focus on managed competition in health care, competitive health insurance market, risk selection, moral hazard, risk equalisation, managed care and priority choices in health care. He has experience as a governor and adviser of insurance companies, political parties, government, research institute, hospitals and other health care organizations. He serves (served) as member of many advisory committees and the editorial Board of scientific journals. As a consultant, e.g. for the World Bank and the World Health Organization, he has studied the health care systems in Chile, Ireland, Israel, New Zealand, Poland, Russia, South Africa and Sweden. He is one of the founding fathers of the European Risk Adjustment Network. Previous positions are Programme Director of the Master Health Economics, Policy and Law at Erasmus University and Chair of the iHEA Jury-Committee for the annual Arrow Award for best paper in health economics.
Erasmus School of Health Policy & Management
- vandeven@eshpm.eur.nl
More information
Work
- Wynand P.M.M. van de Ven & Richard C. van Kleef (2024) - A critical review of the use of R<sup>2</sup> in risk equalization research - European Journal of Health Economics - doi: 10.1007/s10198-024-01709-8 - [link]
- Wynand van de Ven, Konstantin Beck, Florian Buchner, Erik Schokkaert, Erik Schut, A Shmueli & Jürgen Wasem (2024) - Preconditions for efficiency and affordability in competitive healthcare markets: Are they fulfilled in Belgium, Germany, Israel, the Netherlands and Switzerland? Ten years later - Health Policy, 146 - doi: 10.1016/j.healthpol.2024.105099 - [link]
- Richard C. van Kleef, Mieke Reuser, Pieter J.A. Stam & Wynand P.M.M. van de Ven (2024) - A framework for ex-ante evaluation of the potential effects of risk equalization and risk sharing in health insurance markets with regulated competition - Health Economics Review, 14 (1) - doi: 10.1186/s13561-024-00540-4 - [link]
- Josefa Henriquez, Wynand van de Ven, Adrian Melia & Francesco Paolucci (2024) - The roads to managed competition for mixed public–private health systems: a conceptual framework - Health Economics, Policy and Law - doi: 10.1017/S1744133123000373 - [link]
- Wynand van de Ven & Erik Schut (2024) - Zorgstelsel gebaat bij verzekeraars opgericht door zorgaanbieders - Economisch-Statistische Berichten, 109 (4838), 450-453
- Wynand van de Ven, Erik Schut & Marco Varkevisser (2023) - Wetgever moet duidelijkheid geven over vergoeding van niet-gecontracteerde zorg - Economisch-Statistische Berichten, 108 (4824), 2-5 - [link]
- Wynand van de Ven, Gerrit Hamstra, Richard van Kleef, Mieke Reuser & Piet Stam (2023) - The goal of risk equalization in regulated competitive health insurance markets - European Journal of Health Economics, 24 (1), 111-123 - doi: 10.1007/s10198-022-01457-7 - [link]
- Rudy Douven, Lukas Kauer, Sylvia Demme, Francesco Paolucci, Wynand van de Ven, Jürgen Wasem & Xiaoxi Zhao (2022) - Should administrative costs in health insurance be included in the risk-equalization? An analysis of five countries - European Journal of Health Economics, 23 (9), 1437-1453 - doi: 10.1007/s10198-022-01436-y - [link]
- Rudy Douven & Wynand van de Ven (2022) - Neem bedrijfskosten van zorgverzekeraar ook op in de risicoverevening - Economisch-Statistische Berichten, 107 (4815), 513-515 - [link]
- Wynand van de Ven, Gerrit Hamstra, Richard van Kleef, Mieke Reuser & Pieter J.A. Stam (2022) - De wetgever moet het doel van de risicoverevening vaststellen - Economisch-Statistische Berichten - [link]
Economics and Financing
- Year Level
- master, master, master, master
- Year
- 2024
- Course Code
- GW4567M